Bridgefront Capital’s Boston Scientific BSX Stock Holding History

Bridgefront Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.92M	Buy	30,630 +6,862	+29%	+$549K	0.48%	45
2025 Q4	$2.27M	Sell	23,768 -2,550	-10%	-$250K	0.57%	27
2025 Q3	$2.57M	Buy	26,318 +12,471	+90%	+$1.29M	0.76%	7
2025 Q2	$1.49M	Sell	13,847 -6,293	-31%	-$637K	0.39%	42
2025 Q1	$2.03M	Buy	+20,140	New	+$2.03M	0.59%	13
2024 Q4	–	Sell	-6,216	Closed	-$521K	–	595
2024 Q3	$521K	Buy	+6,216	New	+$490K	0.2%	174
2023 Q3	–	Sell	-16,482	Closed	-$892K	–	410
2023 Q2	$892K	Buy	16,482 +12,224	+287%	+$638K	0.48%	34
2023 Q1	$213K	Sell	4,258 -5,291	-55%	-$249K	0.13%	319
2022 Q4	$442K	Buy	+9,549	New	+$413K	0.31%	120
2021 Q1	–	Sell	-56,663	Closed	-$2.04M	–	690
2020 Q4	$2.04M	Buy	+56,663	New	+$2.04M	0.7%	5

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bridgefront Capital's BSX Position: Q1 2026 in Review

Bridgefront Capital increased its Boston Scientific (BSX) stake by 29% in Q1 2026, buying an estimated $549K and bringing the position to 30,630 shares worth $1.92M. The position accounts for 0.48% of the portfolio, ranked #45.

Bridgefront Capital first reported a position in BSX in Q4 2020 and has held it in 10 quarters since. The position peaked at $2.57M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Bridgefront Capital held 30,630 shares of Boston Scientific worth $1.92M as of Q1 2026.
Bridgefront Capital bought 6,862 Boston Scientific shares in Q1 2026, an estimated $549K.
Boston Scientific made up 0.48% of Bridgefront Capital's portfolio in Q1 2026, its #45 holding.
Bridgefront Capital first reported a position in Boston Scientific in Q4 2020 and has held it in 10 quarters since.
Bridgefront Capital's Boston Scientific position peaked at $2.57M in Q3 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Bridgefront Capital's 13F filing for Q1 2026, filed 15 May 2026.